首页> 外文学位 >A study of penicillin-binding proteins in Mycobacterium tuberculosis.
【24h】

A study of penicillin-binding proteins in Mycobacterium tuberculosis.

机译:结核分枝杆菌中青霉素结合蛋白的研究。

获取原文
获取原文并翻译 | 示例

摘要

Penicillin-class antibiotics, known as β-lactams, are one of medicine's most valuable weapons against bacterial disease. These drugs infiltrate susceptible bacteria and interrupt normal growth via interactions with a class of cell wall-synthesizing enzymes known as penicillin-binding proteins (PBPs). Some pathogens, however, can escape such a fate.; Beta-lactam antibiotics are not currently prescribed for the treatment of tuberculosis, although it has now been shown that commercially available lactams can bind to PBPs in membrane fractions from Mycobacterium tuberculosis (MTB), the causative agent.12 13 This lab has previously documented that PBPs form native protein complexes within H. influenzae and E. coli.14 15 If similar PBP complexes could be identified within mycobacteria, it would improve our understanding of the enzymology of cell wall biosynthesis in these organisms. Mycobacterial PBPs and the proteins with which they naturally interact are valuable targets for antibiotic research, especially in light of the emergence of multidrug-resistant tuberculosis (MDRTB) in certain populations worldwide.; The approach outlined here covalently labels PBPs within intact cells before protein isolation; the advantage provided by this scheme is the opportunity to cross-link PBPs in their native protein-protein associations. Cross-linking can take place after interaction with β-lactam tags, but before disruption of cells. This lab has previous experience exploring the topography of bacterial PBPs using cyanogen (ethanedinitrile) as a cross-linking agent.3 4 Cyanogen has been shown to permeate intact cells and to covalently crosslink native PBP complexes.; Dansylated penicillin has been used to covalently label purified serine protease enzymes, though to the best of our knowledge it has not been used to label mycobacterial proteins.16 When accompanied by β-lactamase inhibitors, β-lactams interfere with the growth of mycobacteria in cultures17 18 19 20 and intracellularly within macrophages.21 This project sought to label PBPs and associated enzymes in whole MTB cells with a fluorescent tag, then to isolate these proteins. Both a de novo monocyclic lactam and a commercially available penicillin were dansylated in order to investigate their effectiveness in labeling PBPs within whole mycobacterial cells. We found that mycobacterial PBPs could be fluorescently tagged and cross-linked to associated proteins within intact cells.; 12Chambers, H. F., Moreau, D., Yajko, D., Miick, C., Wagner, C., Hackbarth, C., Kocagoz, S., Rosenberg, E., Hadley, W., Nikaido, H. (1995) Antimicrob. Agents and Chemo. 39, 2620–2624. 13Basu, J., Chattopadhyay, R., Manikuntala, K., Chakrabarti, P. (1992) J. Bacteriol. 174, 4829–4832. 14Alaedini, A., Day, R A. (1999) Biochem. Biophys. Res. Commun. 264, 191–195. 15Bhardwaj, S., Day, R A. (1998) Techniques in Protein Chemistry VIII, Academic Press, San Diego: 469. 16Fink, A. L., Cartwright, S. J. (1989) Biochem. J. 263, 905–912. 17Sorg, T., Cynamon, M. (1987) J. Antimicrob. Chemother. 19(1), 59–64. 18Prabhakaran, K., Harris, E, Randhawa, B, Adams, L, Williams, D., Hastings, R. (1993) Microbios 76(309), 251–61. 19Chen, C., Yand, M., Lin, J., Lee, Y., Perng, R. (1995) Proc. Nat. Sci. Coun. Repub. China B. 19(2),80–84. 20Herbert, D., Paramasivan, C., Venkatesan, P., Kubendiran, G., Prabhakara
机译:青霉素类抗生素,称为β-内酰胺类,是医学上最有价值的抵抗细菌性疾病的武器之一。这些药物通过与称为青霉素结合蛋白(PBPs)的一类细胞壁合成酶的相互作用,渗透到易感细菌中并中断正常生长。但是,某些病原体可以逃脱这种命运。尽管目前已经证明,商业上可买到的内酰胺类可以与致病性<结核>结核分枝杆菌(MTB)的膜级分中的PBPs结合,但目前尚无β-内酰胺类抗生素可用于治疗结核病。 super> 12 13 该实验室先前已证明PBP在流感嗜血杆菌 E中形成天然蛋白复合物。大肠杆菌 14 15 如果在分枝杆菌中可以鉴定出类似的PBP复合物,则将增进我们对这些生物中细胞壁生物合成酶学的理解。分枝杆菌PBP及其与之天然相互作用的蛋白质是抗生素研究的重要目标,特别是考虑到全球某些人群出现了耐多药结核病(MDRTB)。在蛋白质分离之前,本文概述的方法共价标记了完整细胞内的PBP。该方案提供的优势是有机会使PBP与其天然蛋白-蛋白缔合交联。交联可在与β-内酰胺标签相互作用后发生,但在细胞破裂之前发生。该实验室以前曾使用氰化物(乙二腈)作为交联剂探索细菌PBP的形貌。 3 4 氰化物已渗透到完整细胞中并与天然PBP复合物共价交联。丹磺酰青霉素已被用于共价标记纯化的丝氨酸蛋白酶,尽管据我们所知,尚未被用于标记分枝杆菌蛋白。 16 当β-内酰胺酶抑制剂与β-内酰胺酶结合使用时,β-内酰胺会干扰与 <?Eqn TeX input =“ break”> 培养 17 18 19 20 以及在巨噬细胞内的分枝杆菌的生长有关。 21 该项目旨在用荧光标签标记整个MTB细胞中的PBP和相关酶,然后分离这些蛋白。为了研究其在整个分枝杆菌细胞内标记PBP的有效性,对 de novo 单环内酰胺和市售的青霉素都进行了丹磺酰化。我们发现分枝杆菌的PBPs可以被荧光标记并交联到完整细胞内的相关蛋白上。 12 Chambers,HF,Moreau,D.,Yajko,D.,Miick,C.,Wagner,C.,Hackbarth,C.,Kocagoz,S.,Rosenberg,E.,Hadley,W ,Nikaido,H。(1995)<斜体>抗微生物剂。特工和化学。 39 ,2620–2624。 13 Basu,J.,Chattopadhyay,R.,Manikuntala,K.,Chakrabarti,P.(1992)<斜体> J。细菌。 174 ,4829–4832。 14 Alaedini,A.,Day,R.(1999) Biochem。生物物理学。 Res。 264 ,191-195。 15 Bhardwaj,S.,Day,R.(1998),蛋白质化学技术VIII ,学术出版社,圣地亚哥:469。 16 Fink,AL,Cartwright,SJ(1989)<斜体> Biochem。 J。 263 ,905-912。 17 Sorg,T.,Cynamon,M.(1987)<斜体> J。抗微生物剂。 19 (1),59-64。 18 Prabhakaran,K.,哈里斯,E,Randhawa,B,Adams,L,Williams,D.,Hastings,R.(1993) Microbios 76 < / bold>(309),251-61。 19 Chen,C.,Yand,M.,Lin,J.,Lee,Y.,Perng,R.(1995) Proc。纳特科学un重新发布。中国B。 19 (2),80–84。 20 Herbert,D.,Paramasivan,C.,Venkatesan,P.,Kubendiran,G.,Prabhakara

著录项

  • 作者

    Anderson, Lisa Louise.;

  • 作者单位

    University of Cincinnati.;

  • 授予单位 University of Cincinnati.;
  • 学科 Chemistry Biochemistry.; Health Sciences Pharmacology.; Biology Molecular.; Biology Microbiology.
  • 学位 Ph.D.
  • 年度 2001
  • 页码 102 p.
  • 总页数 102
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;药理学;分子遗传学;微生物学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号